These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 15823695)

  • 1. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).
    Heng BC; Cao T
    Med Hypotheses; 2005; 64(6):1105-8. PubMed ID: 15823695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular antibodies (intrabodies) and their therapeutic potential.
    Lo AS; Zhu Q; Marasco WA
    Handb Exp Pharmacol; 2008; (181):343-73. PubMed ID: 18071953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
    Yang X; Hu W; Li F; Xia H; Zhang Z
    Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced intracellular stability of sFv-Fc fusion intrabodies.
    Strube RW; Chen SY
    Methods; 2004 Oct; 34(2):179-83. PubMed ID: 15312671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrabody construction and expression. II. A synthetic catalytic Fv fragment.
    Ohage EC; Wirtz P; Barnikow J; Steipe B
    J Mol Biol; 1999 Sep; 291(5):1129-34. PubMed ID: 10518948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A universal strategy for stable intracellular antibodies.
    Shaki-Loewenstein S; Zfania R; Hyland S; Wels WS; Benhar I
    J Immunol Methods; 2005 Aug; 303(1-2):19-39. PubMed ID: 16045924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pSKAP/S: An expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins.
    Griep RA; van Twisk C; Kerschbaumer RJ; Harper K; Torrance L; Himmler G; van der Wolf JM; Schots A
    Protein Expr Purif; 1999 Jun; 16(1):63-9. PubMed ID: 10336861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a new intrabody directed against the N-terminal region of human p53.
    Cohen PA; Mani JC; Lane DP
    Oncogene; 1998 Nov; 17(19):2445-56. PubMed ID: 9824155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
    Wang X; Campoli M; Ko E; Luo W; Ferrone S
    J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and expression of single chain variable fragments (ScFv) against human CD19 antigen].
    Chen S; Rao Q; Wang JX; Wang M
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):686-91. PubMed ID: 16285505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and binding of intracellular antibody fragments to the hepatitis C virus core protein.
    Heintges T; zu Putlitz J; Wands JR
    Biochem Biophys Res Commun; 1999 Sep; 263(2):410-8. PubMed ID: 10491307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of endoplasmic reticulum-retained anti-type IV collagenase intrabody on invasion and proliferation of cancer cell].
    Shen EY; Wang WG; Li Y; Zhang SH; Zhen YS
    Ai Zheng; 2004 Sep; 23(9):1005-10. PubMed ID: 15363191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells.
    Sibler AP; Courtête J; Muller CD; Zeder-Lutz G; Weiss E
    FEBS J; 2005 Jun; 272(11):2878-91. PubMed ID: 15943819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
    Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
    Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies.
    Strube RW; Chen SY
    J Immunol Methods; 2002 May; 263(1-2):149-67. PubMed ID: 12009211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.